Event Date & TimeClick the calendar icon to add events
to your Personal Calendar

  • SymposiumJun 12, 20208:00 am - 5:00 pmThis event is an accredited group learning activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada (RCPSC), approved by the Canadian Association of Gastroenterology (CAG) for a maximum of 7.5 hours. :: Through an agreement between the Royal College of Physicians and Surgeons of Canada and American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.


UM Bannatyne: Basic Medical Sciences Building: Room-Frederic Gaspard Theatre

University of Manitoba, 745 Bannatyne Ave., Winnipeg, Manitoba, Canada, R3E 0J9

Click to Log In Create an Account

* You must be logged in to purchase event tickets.

This event has been Cancelled. All registrants will be notified shortly. 


$187.50 for practicing physicians. All other professions register at no cost.
You must be a paid registrant to claim continuing education credits for this event.

Attendees must register for an account, add a ticket to their event cart, and complete the check out transaction in order to register. Scroll down to add a ticket to your event cart. 

Join our experts for the 25th Anniversary of this event!

Learning Objectives

  • To develop management approach to eosinophilic esophagitis
  • To understand utility of esophageal diagnostic tests
  • To learn an approach to esophageal motility disorders
  • To learn approach to managing diet in IBS
  • To learn approach to managing prescription or OTC therapy in IBS
  • To learn optimal colon polyp surveillance paradigms
  • To understand approaches to colon cancer screening in different populations
  • To understand about the use of immunosuppressive monotherapy in IBD
  • To learn when and how to withdraw immunomodulatory therapy in IBD
  • To learn the difference between outcomes for biologic therapies in IBD from clinical trials compared to real word experience
  • To contrast what is known about microbial based therapies vs immune based therapies in IBD


All lectures are 20 minutes long, with 10 minutes for discussion

Morning Session

0825 Welcome – Charles Bernstein
0830 Treatment and Follow Up of Eosinophilic Esophagitis – Ikuo Hirano
0900 Approach to Esophageal Motility Disorders – John Pandolfino
0930 IBS: Diet Therapy, Drug Therapy or Both – Premysl Bercik
1000 Panel discussion – Donald Duerksen

1030 Break

1050 Controversies in Colorectal Cancer Screening: Which test is best? – Jason Dominitz
1120 Colon Polyp Follow Up – The Best Evidence – David Lieberman
1150 Panel discussion – Harminder Singh

1230 Lunch

Afternoon Session

1330 Are Immunosuppressives Alive or Dead as Monotherapy in IBD? – Stephen Hanauer
1400 When and How Do You Withdraw Immune Therapy in IBD? – Simon Travis
1430 Do Clinical Trial Data Mirror Real World Practice in IBD? – Laura Targownik

1500 Break

1520 The Future of IBD Treatment: Should We Modulate the Microbiota or Host Immunity? – Matthieu Allez
1550 Panel discussion – Charles Bernstein


Guest Faculty

Matthieu Allez, MD, PHD
Professor of Medicine
Head of the Department of Gastroenterology
Hopital Saint-Louis – Paris, FR

Premysl Bercik, MD
Associate Professor, Division of Gastroenterology
Department of Medicine
Richard Hunt-AstraZeneca Chair in Gastroenterology
McMaster University – Hamilton, ON

Jason Dominitz, MD, MHS
National Director of Gastroenterology for the
Veterans Health Administration
Acting Chief of Gastroenterology for the VA Puget Sound
Professor of Gastroenterology and Medicine
University of Washington – Seattle, WA

Stephen Hanauer, MD
Professor of Medicine
Division of Gastroenterology and Hepatology
Northwestern University – Chicago, IL

Ikuo Hirano, MD
Professor of Medicine
Division of Gastroenterology and Hepatology
Northwestern University – Chicago, IL

David Lieberman, MD
Professor of Medicine
Division of Gastroenterology and Hepatology
School of Medicine
Oregon Health and Science University – Portland, OR

John Pandolfino, MD
Chief of Gastroenterology and Hepatology in the
Department of Medicine
Hans Popper Professor
Professor of Medicine (Gastroenterology and Hepatology)
Northwestern University – Chicago, IL

Laura Targownik, MD, MSHS, FRCPC
Staff Gastroenterologist, Division of Gastroenterology
Departmental Division Director
University of Toronto – Toronto, ON

Simon Travis, DPhil, FRCP
Professor of Clinical Gastroenterology
Translational Gastroenterology Unit
Oxford University – Oxford, UK

Local Faculty

Dr. Charles N. Bernstein
Distinguished Professor of Medicine
Section of Gastroenterology
Director, University of Manitoba
IBD Clinical and Research Centre
Max Rady College of Medicine

Donald Duerksen, MD, FRCPC
Acting Head, Section of Gastroenterology
Professor of Medicine, University of Manitoba
Medical Director – Adult Manitoba Home Nutrition
Program & WRHA Food and Nutrition Services

Harminder Singh, MD, FRCP
Associate Professor of Medicine
Section of Gastroenterology
University of Manitoba


Click to Log In Create an Account

* You must be logged in to purchase event tickets.